Another Connecticut Fundraiser for Teacher with Hodgkin's

And I thought community dinners were a Minnesota thing ;-)



Friends are rallying around Ericka Banhan, a longtime Bethlehem, CT resident employed as a part-time Middle School secretary. Ericka is the wife of self-employed painter Ozzie Banhan and the mother of Alexis, 14, entering her sophomore year in High School, and Brooke, 9, who just completed third grade.



Ericka was diagnosed in April with Stage IV Hodgkin's lymphoma. She has no health insurance.



Friends are coordinating "An Evening for Ericka", a dinner dance and silent auction set for 7 to 11 p.m. Friday, July 15. Gathered recently to finalize details of the event, woman spoke fondly of Ericka. Students love her, they said; despite her illness, she is seldom without a smile.



"Ericka is so fun to be around," said Lisa. "She has so much heart and she's devoted to her kids. She always puts her girls first." "If the situation were reversed, she'd be there for all of us," said Nancy. Gayle Peterson can vouch for that. Nearly 10 years ago, she, too, was diagnosed with Hodgkin's and Ericka was among those offering support.



"I'd be sick from my chemo treatments and Ericka would be there, bringing meals to my door," she said. "She was so helpful. Ericka's a wonderful person."
More in the Voices newspaper.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap